American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2017

Genentech presents new data on MS treatment

American Pharmacy News Reports | Apr 25, 2017
The data described the effect OCREVUS had on patients with relapsing forms of MS and primary progressive MS.

New data on OCREVUS presented at American Academy of Neurology (AAN) annual meeting in Boston. Read More »

AbbVie nets positive results in Phase III hepatitis C drug study

American Pharmacy News Reports | Apr 25, 2017
The results of the clinical trial were presented at The International Liver Congress in Amsterdam.

AbbVie has announced the successful results of an EXPEDITION-1 Phase III study that evaluated 12 weeks of treatment with glecaprevir/pibrentasvir (G/P). Read More »

Togo recognized for eliminating elephantiasis

American Pharmacy News Reports | Apr 25, 2017
LF is transmitted by mosquitoes and can develop into a chronic condition that affects the lymphatic system.

Togo became the first country in Africa recognized by the World Health Organization for eliminating lymphatic filariasis, also known as elephantiasis, as a public health problem. Read More »

Collaboration to develop biomarker technology

American Pharmacy News Reports | Apr 25, 2017
A biomarker is a molecule that allows researchers to non-invasively diagnose and monitor the progression of a disease or condition.

A collaboration to develop biomarker technology was announced by Bristol-Myers Squibb Co. and Nordic Bioscience last week. Read More »

PCMA urges FDA to consider competitive drug pricing

American Pharmacy News Reports | Apr 26, 2017

The Pharmaceutical Care Management Association (PCMA) has recommended that the next Food and Drug Administration (FDA) director adopt five specific strategies to encourage pharmaceutical pricing competition based on results of its recently commissioned report. Read More »

European authorities grant Shire's Natpar approval for human use

Mark Iandolo | Apr 28, 2017
Hypoparathyroidism is the last endocrine disorder for which there is no hormone treatment.

Shire PLC's Natpar, an adjunctive treatment for adult patients with chronic hypoparathyroidism, was reviewed positively by the Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More »

GSK, Innoviva see positive results in Relvar Ellipta asthma study

American Pharmacy News Reports | Apr 28, 2017

GlaxoSmithKline (GSK) and Innoviva Inc. recently released positive results for a study evaluating Relvar Ellipta in treating asthma. Read More »

Albertson's trains almost 3,000 pharmacists to administer naloxone

American Pharmacy News Reports | Apr 28, 2017
Many states Albertson's operates in allow pharmacies to dispense Naxolone without prescription.

Albertson’s Cos. have trained close to 3,000 pharmacists in administering naloxone to treat patients overdosing on opioids. Read More »

Genentech sees positive results for Phase II study combining Tecentriq

American Pharmacy News Reports | Apr 29, 2017
Genentech is also evaluating the combination of Tecentriq and Avastin compared to sunitinib in a Phase III study.

Genentech's Phase II Mmotion150 study for Tecentriq compared Tecentriq plus Avastin and Tecentriq monotherapy to sunitinib alone reinforced the potential of the combination drug for the treatment of patients with previously untreated, locally advanced or metastatic renal cell carcinoma. Read More »

Report on asthma management taps allergy immunotherapy as treatment

American Pharmacy News Reports | Apr 29, 2017
ALK’s ACARIZAX is approved in 12 European countries and Australia.

The Global Initiative for Asthma’s report, Global Strategy for Asthma Management and Prevention, is recommending allergy immunotherapy as a treatment option. Read More »

Tivantinib's Phase III study fails to meet primary endpoint

American Pharmacy News Reports | Apr 29, 2017
The METIV-HCC Phase 3 study evaluated tivantinib for treating patients with MET-overexpressing, inoperable HCC.

ArQule Inc. and Daiichi Sankyo's METIV-HCC Phase 3 study of tivantinib in hepatocellular carcinoma failed to meet its primary endpoint of improving overall survival. Read More »

Allergan to sponsor Alzheimer's Foundation of America's education tour

American Pharmacy News Reports | Apr 29, 2017
The tour will involve educational conferences that give individuals a chance to learn from dementia and caregiver experts.

Allergan will sponsor the Alzheimer's Foundation of America's (AFA) "15th Anniversary National Educating America Tour” that honors AFA’s 15 years of Alzheimer’s education. Read More »

Allergan raises awareness of Chronic Dry Eye

American Pharmacy News Reports | Apr 29, 2017
The redness, itching and watering eyes associated with Chronic Dry Eye can often send the wrong message.

Allergan recently announced a new campaign to raise awareness for Chronic Dry Eye, using the slogan “before we had our voice, we had eyes.” Read More »

CVS Health opens MinuteClinic in nation's capital

American Pharmacy News Reports | May 1, 2017
The new clinic in Washington will be open weekdays with no appointments necessary.

CVS Health recently opened a MinuteClinic walk-in medical clinic inside the CVS Pharmacy store on K Street NW in Washington D.C. Read More »

Shire publishes results of lanadelumab study in New England Journal of Medicine

American Pharmacy News Reports | May 1, 2017
In this Phase 1b study, no serious adverse events or discontinuations due to adverse events were observed at all doses studied.

Shire PLC has published results from its Phase 1b lanadelumab study in the New England Journal of Medicine. Read More »

Purdue Pharma welcomes new OTC business lead

American Pharmacy News Reports | May 1, 2017
Carrie Chomiak will work with the company's OTC assets, development, implementation, communication and more.

Purdue Pharma LP's Carrie Chomiak will be stepping up into a substantial business role as lead of over-the-counter product franchise for brands including Betadine microbicide antiseptics, Slow-Mag magnesium chloride supplements, Senokot laxative and Colace stool softener. Read More »

Biologics chosen as specialty pharmacy provider for ZEJULA

Carrie Bradon | May 1, 2017
The American Cancer Society states that there are more than 22,000 women who will be diagnosed with ovarian cancer this year.

Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by Tesaro Inc. to provide its new drug. Read More »

Pharmacy Benefits Managers can be more affordable option than drugstores

American Pharmacy News Reports | May 1, 2017
The new agenda of drugstores would seek to increase their profit, while costing consumers more.

The Pharmaceutical Care Management Association is beginning the DrugBenefitSolutions national campaign, in which it seeks to explain how pharmacy benefits managers are helping to reduce the price of medications and assist consumers, as well as employers and unions. Read More »

Whistleblowers encouraged to deliver accurate information

American Pharmacy News Reports | May 2, 2017
Whistleblowing could prevent injuries and yield rewards for individuals.

The Corporate Whistleblower Center is encouraging individuals to reach out to authorities if they know of unsanitary pharmacy practices. Read More »

Martin to join Purdue Pharma as VP of corporate affairs

Carrie Bradon | May 2, 2017
Josie Martin has held positions at Ketchum, the Federation of American Hospitals and the American Red Cross.

Josie Martin has been named vice president of corporate affairs and communications for Purdue Pharma LP. Read More »

  • «
  • 1
  • 2
  • ...
  • 16
  • 17
  • 18 (current)
  • 19
  • 20
  • ...
  • 36
  • 37
  • »
Trending

 B. Douglas Hoey CEO

NCPA urges government action on pharmacy benefit managers' practices

John Kirtley Executive Director at Arkansas State Board of Pharmacy

Women's health block party to launch National Women's Health Month at Arkansas State Capitol

John Kirtley Executive Director at Arkansas State Board of Pharmacy

Arkansas Health Department extends hours for REAL ID birth certificate requests

 B. Douglas Hoey CEO

NCPA releases new "Show Me" episodes about maternal vaccination programs

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up